Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) accumulation in tumours has been well investigated, but much less is known regarding FDG accumulation in inflammatory lesions. In this study, we determined the effects of hypo- and hyperglycaemia on FDG uptake in inflammatory lesions of infectious and non-infectious origin and compared them with those in malignant tumours in rats, to provide a biological basis for differentiating malignant lesions from benign lesions by means of FDG-PET. Rats were inoculated with a suspension of allogenic hepatoma cells (KDH-8) or Staphylococcus aureus, or with turpentine oil into the left calf muscle. Two weeks after KDH-8 inoculation and 1 week after S. aureus and turpentine oil inoculations, the rats were divided into three subgroups: insulin-loaded (2 U/kg body weight, i.p.), glucose-loaded (1.2 g/kg body weight, p.o.) and control groups. Radioactivity in tissues was determined 1 h after i.v. injection of FDG. Intraperitoneal injection of insulin and oral administration of glucose induced hypoglycaemia and hyperglycaemia, respectively. In the control animals, tumours showed a level of FDG uptake which was 2.2 and 3.0 times higher than the levels in the inflammatory lesions induced by S. aureus and turpentine oil, respectively (P<0.0001). There was no significant difference in the level of FDG uptake between the two inflammatory lesions of infectious and non-infectious origin. Insulin loading significantly decreased the level of FDG uptake in tumours and in both types of inflammatory lesion to approximately one-half of the control values (P=0.001 in the tumour group and P<0.0001 in the two inflammatory lesion groups). In the glucose-loaded group, the level of FDG uptake in both types of inflammatory lesion decreased significantly to 50%-61% of the control value (P=0.0002 in the S. aureus group and P<0.0001 in the turpetine group), while the tumour uptake did not decrease significantly (86% of the control value) (P=NS). It is concluded that FDG uptake in both types of inflammatory lesion was significantly impaired in rats with hyperglycaemia induced by glucose loading, while tumour uptake of FDG was not significantly affected. These results indicate that glucose loading has greater effects on FDG uptake in inflammatory lesions than in tumours, providing a biological basis for differentiation of malignant lesions from benign lesions by FDG-PET in a clinical setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, unnecessary interventions aimed at lowering the BGL are time-and resources-consuming, including insulin injection, which may also increase background FDG uptake and therefore decrease PET scan sensitivity [42].”
In the citing paper
“or the possibility of insulin-induced FDG shunting from tumors to muscles, thus decreasing tumor to background FDG uptake ratio [42,112,113].”
In the citing paper
“This approach may lead to increased costs, inconvenience for patients, unnecessary postponing of PET scan, and delays in diagnosis of potential malignancies”
Citations
Cites
Flier, J. S., Mueckler, M. M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 786 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [1, 2, 3, 4, 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisati…”
BackgroundWahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., Oster, Z. H., Sacker, D. F., Shiue, C. Y., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [ 1 , 2, 3, 4, 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisa…”
Background(1995) · PubMed · Cited by 474
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1557 · Cited by 459 · cited 1×
“It is well known that glucose uptake in peripheral tissues is impaired in infectious diseases owing to peripheral insulin resistance mediated by Glut-4 transporter [31, 32 ].”
BackgroundWahl, R. L., Cody, R. L., Hutchins, G. D., & Mudgett, E. E. (1991) · Radiology · doi:10.1148/radiology.179.3.2027989 · Cited by 431
Wahl, R. L., Quint, L. E., Greenough, R. L., Meyer, C. R., White, R. I., & Orringer, M. B. (1994) · Radiology · doi:10.1148/radiology.191.2.8153308 · Cited by 430
(1993) · PubMed · Cited by 398
Steinert, H. C., Hauser, M., Allemann, F., Engel, H., Berthold, T., von Schulthess, G. K., & Weder, W. (1997) · Radiology · doi:10.1148/radiology.202.2.9015071 · Cited by 376
Differential diagnosis of lung tumor with positron emission tomography: A prospective study
(1991) · Lung Cancer · doi:10.1016/0169-5002(91)90324-y · Cited by 321
Cited by
Zhuang, H., & Alavi, A. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29278 · Cited by 524
18F-FDG PET and PET/CT in fever of unknown origin.
Meller, J., Sahlmann, C., & Scheel, A. (2007) · PubMed · Cited by 323
on behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM), Bucerius, J., Hyafil, F., Verberne, H. J., Slart, R. H. J. A., Lindner, O., Sciagra, R., Agostini, D., Übleis, C., Gimelli, A., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3259-3 · Cited by 257
“tious lesions [27, 28].”
Positron emission tomography imaging in nonmalignant thoracic disorders
Alavi, A., Gupta, N., Alberini, J.-L., Hickeson, M., Adam, L.-E., Bhargava, P., & Zhuang, H. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.127291 · Cited by 218
De Winter, F., Vogelaers, D., Gemmel, F., & Dierckx, R. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0708-2 · Cited by 195
Metadata
- Authors
- Zhao, S., Kuge, Y., Tsukamoto, E., Mochizuki, T., Kato, T., Hikosaka, K., Hosokawa, M., Kohanawa, M., & Tamaki, N.
- Affiliations
- Hokkaido University (JP)
- Nikko Memorial Hospital (JP)
- Corresponding author
- Kuge, Yuji
- Venue
- European Journal of Nuclear Medicine
- Published
- 2001-06
- Volume
- 28
- Issue
- 6
- Pages
- 730-735
- ISSN
- 1619-7070 (ISSN-L)
- 0340-6997
- 1619-7089
- OpenAlex
- W1561754985
- Cited by
- 68
- References
- 32
- Citations by year
- 2026: 5 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- insulin, glucose load, hypoglycemia, hyperglycemia, cancer, inflammatory lesions, FDG-PET, Staphylococcus aureus infection, turpentine-induced inflammation, rats, tumor glucose metabolism
- MeSH terms
- Animals, Blood Glucose, Glucose, Hypoglycemic Agents, Inflammation, Insulin, Liver Neoplasms, Experimental, Male, Neoplasm Transplantation, Radionuclide Imaging, Staphylococcal Infections, Tissue Distribution, Rats, Wistar, Radiopharmaceuticals, Fluorodeoxyglucose F18, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. https://app.cochat.ai/papers/10.1007/s002590100517
- The paper
- Zhao, S., Kuge, Y., Tsukamoto, E., Mochizuki, T., Kato, T., Hikosaka, K., Hosokawa, M., Kohanawa, M., & Tamaki, N. (2001). Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. European Journal of Nuclear Medicine. https://doi.org/10.1007/s002590100517
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.